Published in Hepatitis Weekly, October 28th, 1996
Researcher Johanna Goldfarb and colleagues compared the immunogenicity and safety of 5- and 10-(mu)g doses of the Engerix-B recombinant hepatitis B virus vaccine (SmithKline Beecham Pharmaceuticals, Conshohocken, PA) and found that 10-(mu)g doses appear to be safe in both groups and may offer longer protection.
Vaccination with hepatitis B vaccine is the most effective means of preventing HBV infection. The American Academy of Pediatrics and the Advisory...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly